Kapitał Własny I Rezerwy Zmiana Data
AbbVie USD -4.58B 1.35B 2026-09
Acadia Pharmaceuticals USD 1.39B 80.88M 2026-09
ALKERMES USD 1.86B 56.17M 2026-09
Amgen USD 14.35B 2.66B 2026-09
Biogen USD 19.04B 194.3M 2026-09
BioMarin Pharmaceutical USD 6.26B 65.66M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Coherus Biosciences USD 60.84M 17.78M 2026-06
Eli Lilly USD 40.27B 6.39B 2026-09
Gilead Sciences USD 13.04B 1.3B 2026-09
Heron Therapeutics USD 4.92M 1.99M 2026-09
Ionis Pharmaceuticals USD 393.64M 46.1M 2026-09
J&J USD 81.53B 3.44B 2026-09
Malin Corporation EUR 193.2M 75M 2024-12
Merck USD 44.89B 2.96B 2026-09
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Neurocrine Biosciences USD 3.88B 185.1M 2026-09
Otsuka Holdings JPY 3.29T 45.95B 2026-09
Ovoca Bio EUR 780K 485K 2025-12
Pfizer USD 89B 3.81B 2026-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Vertex Pharmaceuticals USD 20.91B 659.5M 2026-09